BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006;2006:78380. [PMID: 17047295 DOI: 10.1155/MI/2006/78380] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Shaker O, Mahfouz H, Salama A, Medhat E. Long Non-Coding HULC and miRNA-372 as Diagnostic Biomarkers in Hepatocellular Carcinoma. Rep Biochem Mol Biol 2020;9:230-40. [PMID: 33178874 DOI: 10.29252/rbmb.9.2.230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, Aghdassi AA, Metges CC, Garbe LA, Jaster R, Lerch MM, Lamprecht G, Valentini L. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis. Int J Mol Sci 2020;21:E5357. [PMID: 32731496 DOI: 10.3390/ijms21155357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
3 Wu Z, Yang L, He L, Wang L, Peng L. Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:4763675. [PMID: 32382293 DOI: 10.1155/2020/4763675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Andrighetto LV, Poziomyck AK. SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE. Arq Bras Cir Dig 2016;29:276-8. [PMID: 28076486 DOI: 10.1590/0102-6720201600040015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Wang CI, Chu PM, Chen YL, Lin YH, Chen CY. Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC. Int J Mol Sci 2021;22:13627. [PMID: 34948424 DOI: 10.3390/ijms222413627] [Reference Citation Analysis]
6 Chang ML, Yang Z, Yang SS. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. Int J Mol Sci 2020;21:E8308. [PMID: 33167521 DOI: 10.3390/ijms21218308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jiang X, Zhuang Y, Xu Z, Wang W, Zhou H. Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein-Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6. AAPS J 2016;18:767-76. [PMID: 26961818 DOI: 10.1208/s12248-016-9890-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
8 Elaghori A, Salem PES, Azzam E, Abu Elfotoh N. GHRELIN LEVEL IN PATIENTS WITH LIVER CIRRHOSIS. Acta Endocrinol (Buchar) 2019;-5:62-8. [PMID: 31149061 DOI: 10.4183/aeb.2019.62] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Jiménez-Cortegana C, García-Galey A, Tami M, Del Pino P, Carmona I, López S, Alba G, Sánchez-Margalet V. Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines 2021;9:762. [PMID: 34209386 DOI: 10.3390/biomedicines9070762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Flannery PC, Abbott KL, Pondugula SR. Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients. Eur J Drug Metab Pharmacokinet 2020;45:297-304. [PMID: 31792727 DOI: 10.1007/s13318-019-00595-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Matsumura T, Arai M, Yonemitsu Y, Maruoka D, Tanaka T, Suzuki T, Yoshikawa M, Imazeki F, Yokosuka O. The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol. 2010;45:300-307. [PMID: 19997944 DOI: 10.1007/s00535-009-0166-z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
12 Yuan J, Wang Y, Wang X, Zhang W, Ding R, Yue S, Li X. Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma. Front Oncol 2022;12:924059. [DOI: 10.3389/fonc.2022.924059] [Reference Citation Analysis]
13 Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci 2017;18:E405. [PMID: 28216578 DOI: 10.3390/ijms18020405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Metwaly HA, Al-Gayyar MM, Eletreby S, Ebrahim MA, El-Shishtawy MM. Relevance of serum levels of interleukin-6 and syndecan-1 in patients with hepatocellular carcinoma. Sci Pharm. 2012;80:179-188. [PMID: 22396913 DOI: 10.3797/scipharm.1110-07] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
15 Karam HA, Bessa SS, Ali EMM, Diab T, Mohamed TM. The Inter-Relation between Leptin Receptor (Q223R) Gene Polymorphism and the Risk of Egyptian Patients with HCC. Asian Pac J Cancer Prev 2020;21:3557-65. [PMID: 33369452 DOI: 10.31557/APJCP.2020.21.12.3557] [Reference Citation Analysis]
16 Iacob SA, Iacob DG. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Front Endocrinol 2022;13:814209. [DOI: 10.3389/fendo.2022.814209] [Reference Citation Analysis]
17 Capone F, Guerriero E, Sorice A, Colonna G, Storti G, Pagliuca J, Castello G, Costantini S. Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines. ScientificWorldJournal 2014;2014:450390. [PMID: 24701168 DOI: 10.1155/2014/450390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Košuta I, Mrzljak A, Kolarić B, Vučić Lovrenčić M. Leptin as a Key Player in Insulin Resistance of Liver Cirrhosis? A Cross-Sectional Study in Liver Transplant Candidates. J Clin Med 2020;9:E560. [PMID: 32092909 DOI: 10.3390/jcm9020560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
19 Dondeti MF, El-Maadawy EA, Talaat RM. Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol 2016; 22(30): 6800-6816 [PMID: 27570418 DOI: 10.3748/wjg.v22.i30.6800] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
20 Chen Y, Song X, Valanejad L, Vasilenko A, More V, Qiu X, Chen W, Lai Y, Slitt A, Stoner M, Yan B, Deng R. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology 2013;57:1530-41. [PMID: 23213087 DOI: 10.1002/hep.26187] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
21 Nidamanuri AL, Leslie Leo Prince L, Yadav SP, Bhattacharya TK, Konadaka SRR, Bhanja SK. Effect of Supplementation of Fermented Yeast Culture on Hormones and Their Receptors on Exposure to Higher Temperature and on Production Performance after Exposure in Nicobari Chickens. Int J Endocrinol 2021;2021:5539780. [PMID: 34394347 DOI: 10.1155/2021/5539780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Guerriero E, Sorice A, Capone F, Costantini S, Palladino P, D'ischia M, Castello G. Effects of lipoic acid, caffeic acid and a synthesized lipoyl-caffeic conjugate on human hepatoma cell lines. Molecules 2011;16:6365-77. [PMID: 21796075 DOI: 10.3390/molecules16086365] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
23 Othman MS, Aref AM, Mohamed AA, Ibrahim WA. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatol 2013;2013:412317. [PMID: 27335826 DOI: 10.1155/2013/412317] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
24 Jiang Y, Ma Z, Xin G, Yan H, Li W, Xu H, Hao C, Niu J, Zhao P. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm. 2010;2010:143026. [PMID: 21127728 DOI: 10.1155/2010/143026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
25 Yang DH, Ye ZY, Jin B, He XJ, Zhang Q, Zhou WM, Xu WJ, Lu HX. Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats. World J Gastroenterol 2011; 17(14): 1903-1909 [PMID: 21528066 DOI: 10.3748/wjg.v17.i14.1903] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Zhang L, Yuan Q, Li M, Chai D, Deng W, Wang W. The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis. BMC Cancer 2020;20:1167. [PMID: 33256658 DOI: 10.1186/s12885-020-07651-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Naguib R, Fayed A, Elkemary E, Naguib H. Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC). Cureus 2021;13:e20288. [PMID: 34912653 DOI: 10.7759/cureus.20288] [Reference Citation Analysis]
28 Sever S, White DL, Garcia JM. Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review. Endocr Relat Cancer 2016;23:R393-409. [PMID: 27552970 DOI: 10.1530/ERC-16-0130] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
29 Ohno T, Yanai M, Ando H, Toyomasu Y, Ogawa A, Morita H, Ogata K, Mochiki E, Asao T, Kuwano H. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol 2011;4:291-6. [PMID: 22235173 DOI: 10.2147/CEG.S26297] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
30 Tahmasebi Birgani M, Carloni V. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Int J Mol Sci 2017;18:E405. [PMID: 28216578 DOI: 10.3390/ijms18020405] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 14.4] [Reference Citation Analysis]
31 Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in Liver Cirrhosis. Int J Mol Sci 2017;18:E1392. [PMID: 28661458 DOI: 10.3390/ijms18071392] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
32 Matsumura T, Arai M, Yoshikawa M, Sudo K, Nakamura K, Katsuno T, Kanai F, Yamaguchi T, Yokosuka O. Changes in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma. ISRN Gastroenterol 2013;2013:415450. [PMID: 23533792 DOI: 10.1155/2013/415450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Kong L, Zhou Y, Bu H, Lv T, Shi Y, Yang J. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice. J Exp Clin Cancer Res 2016;35:131. [PMID: 27589954 DOI: 10.1186/s13046-016-0412-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 12.5] [Reference Citation Analysis]
34 Capone F, Guerriero E, Colonna G, Maio P, Mangia A, Castello G, Costantini S. Cytokinome profile evaluation in patients with hepatitis C virus infection. World J Gastroenterol 2014; 20(28): 9261-9269 [PMID: 25071319 DOI: 10.3748/wjg.v20.i28.9261] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
35 Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol 2018;4:182-90. [PMID: 30324143 DOI: 10.5114/ceh.2018.78122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
36 Yang DH, Ye ZY, Jin B, He XJ, Zhang Q, Zhou WM, Xu WJ, Lu HX. Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats. World J Gastroenterol. 2011;17:1903-1909. [PMID: 21528066 DOI: 10.3748/wig.v17.i14.1903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Elkabbany ZA, Hamza RT, Mahmoud NH. Assessment of serum acylated ghrelin in children and adolescents with chronic liver diseases: relation to nutritional status. Scientific World Journal. 2014;2014:560516. [PMID: 25379540 DOI: 10.1155/2014/560516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Yang P, Markowitz GJ, Wang XF. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. Natl Sci Rev 2014;1:396-412. [PMID: 25741453 DOI: 10.1093/nsr/nwu038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
39 Zhang X, Zhai L, Rong C, Qin X, Li S. Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population. PLoS One 2015;10:e0143069. [PMID: 26599409 DOI: 10.1371/journal.pone.0143069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
40 Huang Y, Wang T, Yang J, Wu X, Fan W, Chen J. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review. Int J Nanomedicine 2022;17:2335-52. [PMID: 35619893 DOI: 10.2147/IJN.S363456] [Reference Citation Analysis]
41 Petrescu AD, Grant S, Williams E, An SY, Seth N, Shell M, Amundsen T, Tan C, Nadeem Y, Tjahja M, Weld L, Chu CS, Venter J, Frampton G, McMillin M, DeMorrow S. Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis. Am J Pathol 2022;192:484-502. [PMID: 34896073 DOI: 10.1016/j.ajpath.2021.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 He F, Dai S, Xiao Z, Wang L, Yue Z, Zhao H, Zhao M, Lin Q, Dong X, Liu F. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Biomed Res Int 2016;2016:3681731. [PMID: 27975051 DOI: 10.1155/2016/3681731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
43 Saxena R, Chawla YK, Verma I, Kaur J. IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India. Mol Cell Biochem. 2014;385:297-307. [PMID: 24101445 DOI: 10.1007/s11010-013-1838-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]